Disarm Therapeutics

Developer of therapeutics for the treatment of neurological diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2016 groups3 employees language disarmtx.com

Registered entities

Innovation

20 patent families (13 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 1,614 times.

YearFilings
20181
20194
20205
202112
202215
20239
202411
202510
20266

Investor mix

5 investors on record; lead investors include Atlas Venture.

Investor typeCountShare
Venture capital480%
Other / undisclosed120%
Coming soon